在阿尔茨海默氏病连续体内的小脑亚区域结构变化:对认知和行为相关的纵向分析
Yoo Hyun Um1, Sheng-Min Wang2, Dong Woo Kang3
1Department of Psychiatry, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Brain communications
|January 12, 2026
概括
小脑在阿尔茨海默氏症 (AD) 中没有被遗弃,显示了与认知和行为变化相关的早期缩. 这种退化会影响记忆,情绪和执行功能,突出显示小脑在阿尔茨海默病进展过程中的作用.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 放射学 放射学是指放射学
背景情况:
- 阿尔茨海默氏症 (AD) 传统上省略了小脑,但新出现的证据突显了它在认知和行为功能障碍中的作用.
- 在AD连续体中对亚区域小脑干预的纵向数据有限.
研究的目的:
- 为了研究纵向小脑缩及其临床相关的个体在AD连续的个人.
- 用生物标志物定义的群体绘制亚区域小脑变化及其与认知和行为症状的关联.
主要方法:
- 从四个生物标志物定义的AD组 (对照组,临床前AD,AD导致的MCI,AD痴呆症) 的259名老年人结构性MRI数据的纵向分析.
- 使用空间无偏差的低垂体模板 (SUIT) 来评估28个小脑子子区域的纵向变化.
- 在概括估计方程分析中对人口和生物共变量进行控制.
主要成果:
- 在临床前阿尔茨海默病的小脑结构变化与认知和行为变化相关.
- 叶片VI和Crus I/II的减少与情节性记忆力下降和神经精神症状如冷漠有关.
- 观察到依赖阶段的皮质-大脑合,在临床前阿尔茨海默病与痴呆症阶段有不同的模式.
结论:
- 在阿尔茨海默氏症中,小脑退化早期出现,并与皮质网络进行动态相互作用,影响认知衰退和神经精神病症状.
- 显著的缩模式和皮层-小脑脱表明小脑作为疾病阶段特定的生物标志物和AD治疗点的潜力.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
801
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
801
Cognitive Development During Adulthood
766
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
766
Dementia
508
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
508
Cerebellum: Anatomical Regions
4.0K
The cerebellum, also known as the "little brain," is located in the posterior cranial fossa, inferior to the tentorium cerebelli and dorsal to the brainstem. It plays a significant role in motor control, coordination, and proprioception.
Cerebellar Structure
Externally, the cerebellum features a highly convoluted surface with numerous folia (narrow ridges) separated by shallow sulci (grooves). The cerebellum is divided into two hemispheres by a thin median structure known as the vermis. The...
Cerebellar Structure
Externally, the cerebellum features a highly convoluted surface with numerous folia (narrow ridges) separated by shallow sulci (grooves). The cerebellum is divided into two hemispheres by a thin median structure known as the vermis. The...
4.0K


